Fig. 5.

Plasma ceramides levels. (A) Shows the concentration of ceramide species at week 0 (upper panel) and at week 16 (lower panel), and (B) shows the total ceramides concentration. Plasma ceramide levels were indistinguishable between PEMF-treated (Blue) and control (Red) cohorts at study commencement (week 0). The bar charts in (C) shows the normalized values of specific lysophosphatidylcholine species before and after 16 weeks from the date of ACLR. Blue bars represent those subjects receiving magnetic intervention; Red bars represent the sham control cohort. The data were analysed using two-sample paired t-test, with ∗p ​< ​0.05 and ∗∗p ​< ​0.01 and the error bars represent the standard error of the mean. N ​= ​8 for control group and N ​= ​9 for PEMF group.